EXAGEN INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- EXAGEN INC. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $22.00K.
- EXAGEN INC. stock issued during period, value, stock options exercised for the quarter ending 2023-03-31 was $27.00K.
- EXAGEN INC. stock issued during period, value, stock options exercised for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- EXAGEN INC. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $1.00K.
- EXAGEN INC. stock issued during period, value, stock options exercised for fiscal 2024 was $22.00K, a 18.52% decline from fiscal 2023.
- EXAGEN INC. stock issued during period, value, stock options exercised for fiscal 2023 was $27.00K, a 55.74% decline from fiscal 2022.
- EXAGEN INC. stock issued during period, value, stock options exercised for fiscal 2022 was $61.00K, a 31.46% decline from fiscal 2021.
- EXAGEN INC. stock issued during period, value, stock options exercised for fiscal 2021 was $89.00K, a 584.62% increase from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-12-31 | $22.00K 10-K · filed 2026-03-10 | |
| 2024-09-30 | $22.00K 10-Q · filed 2025-11-04 | |
| 2023-12-31 | $27.00K 10-K · filed 2025-03-11 | |
| 2023-03-31 | $27.00K 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $61.00K 10-K · filed 2024-03-18 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-21 | |
| 2021-12-31 | $89.00K 10-K · filed 2023-03-20 | |
| 2021-09-30 | $1.00K 10-Q · filed 2022-11-21 | |
| 2021-06-30 | $35.00K 10-Q/A · filed 2022-11-21 | |
| 2021-03-31 | $44.00K 10-Q/A · filed 2022-11-21 | |
| 2020-12-31 | $13.00K 10-K · filed 2022-03-22 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $2.00K 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $10.00K 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $4.00K 10-K · filed 2021-03-16 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-11-12 | |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |